HK1050326A1 - Stable liquid preparation comprising sitafloxacin - Google Patents

Stable liquid preparation comprising sitafloxacin

Info

Publication number
HK1050326A1
HK1050326A1 HK03102562A HK03102562A HK1050326A1 HK 1050326 A1 HK1050326 A1 HK 1050326A1 HK 03102562 A HK03102562 A HK 03102562A HK 03102562 A HK03102562 A HK 03102562A HK 1050326 A1 HK1050326 A1 HK 1050326A1
Authority
HK
Hong Kong
Prior art keywords
sitafloxacin
liquid preparation
stable liquid
stable
preparation
Prior art date
Application number
HK03102562A
Other languages
English (en)
Inventor
Araki Masanori
Nakagami Hiroaki
Matsukawa Azusa
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1050326A1 publication Critical patent/HK1050326A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
HK03102562A 2000-04-24 2003-04-09 Stable liquid preparation comprising sitafloxacin HK1050326A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000127622 2000-04-24
JP2000149812 2000-05-17
PCT/JP2001/003457 WO2001080858A1 (fr) 2000-04-24 2001-04-23 Preparation liquide stable

Publications (1)

Publication Number Publication Date
HK1050326A1 true HK1050326A1 (en) 2003-06-20

Family

ID=26590975

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102562A HK1050326A1 (en) 2000-04-24 2003-04-09 Stable liquid preparation comprising sitafloxacin

Country Status (20)

Country Link
US (1) US7304075B2 (ja)
EP (1) EP1277471B1 (ja)
JP (1) JP5027975B2 (ja)
KR (1) KR100858228B1 (ja)
CN (1) CN1326524C (ja)
AR (1) AR028028A1 (ja)
AT (1) ATE396729T1 (ja)
AU (1) AU2001248833A1 (ja)
BR (1) BR0110290A (ja)
CA (1) CA2406849C (ja)
DE (1) DE60134221D1 (ja)
DK (1) DK1277471T3 (ja)
ES (1) ES2305065T3 (ja)
HK (1) HK1050326A1 (ja)
MX (1) MXPA02010497A (ja)
NO (1) NO323810B1 (ja)
PT (1) PT1277471E (ja)
RU (1) RU2295342C2 (ja)
TW (1) TWI280131B (ja)
WO (1) WO2001080858A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
KR101016595B1 (ko) 2002-07-31 2011-02-22 센주 세이야꾸 가부시키가이샤 수성액제 및 광안정화된 수성액제
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
WO2008023807A1 (fr) 2006-08-25 2008-02-28 Astellas Pharma Inc. Composition pharmaceutique stabilisée
JP5258331B2 (ja) * 2008-03-03 2013-08-07 ロート製薬株式会社 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
CN101690712B (zh) * 2009-08-25 2011-06-15 武汉武药科技有限公司 一种西他沙星滴眼剂及其制备方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
SG11201408511QA (en) * 2012-06-27 2015-01-29 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622973B (zh) * 2013-12-02 2016-05-11 广东恒诚制药有限公司 一种复方醋酸曲安奈德溶液的制备方法
AT524927A1 (de) * 2021-04-07 2022-10-15 Engel Austria Gmbh Plastifiziereinheit für eine Formgebungsmaschine und Verfahren zum Betreiben einer solchen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
AU5449590A (en) 1989-04-28 1990-11-29 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
RU2044544C1 (ru) 1989-04-28 1995-09-27 Дайити Фармасьютикал Ко., Лтд Композиция против вируса иммунодефицита человека

Also Published As

Publication number Publication date
NO20025081L (no) 2002-12-23
RU2295342C2 (ru) 2007-03-20
NO323810B1 (no) 2007-07-09
BR0110290A (pt) 2003-02-18
TWI280131B (en) 2007-05-01
EP1277471B1 (en) 2008-05-28
CN1326524C (zh) 2007-07-18
US20030139436A1 (en) 2003-07-24
NO20025081D0 (no) 2002-10-22
CN1438888A (zh) 2003-08-27
KR20020089523A (ko) 2002-11-29
EP1277471A1 (en) 2003-01-22
ATE396729T1 (de) 2008-06-15
CA2406849C (en) 2007-10-23
PT1277471E (pt) 2008-08-26
DE60134221D1 (de) 2008-07-10
MXPA02010497A (es) 2003-05-14
KR100858228B1 (ko) 2008-09-12
AU2001248833A1 (en) 2001-11-07
AR028028A1 (es) 2003-04-23
ES2305065T3 (es) 2008-11-01
US7304075B2 (en) 2007-12-04
EP1277471A4 (en) 2006-04-12
WO2001080858A1 (fr) 2001-11-01
CA2406849A1 (en) 2002-10-21
JP5027975B2 (ja) 2012-09-19
DK1277471T3 (da) 2008-08-11
RU2002128631A (ru) 2004-03-27

Similar Documents

Publication Publication Date Title
GB2359254B (en) Formulation
AU6383901A (en) Liquid formulations
AU2001263839A1 (en) Liquid formulations
HK1050326A1 (en) Stable liquid preparation comprising sitafloxacin
GB0000891D0 (en) Formulation
AP2003002783A0 (en) Medicament containing activted antihtrombin iii
EP1293206A4 (en) LIQUID PREPARATION BASED ON WATER
GB2368735B (en) Oscillator
HK1054508A1 (zh) 新型製劑
AU2001232344A1 (en) Liquid preparation with improved absorbability
HU0000101V0 (en) Multiple-purpose corner-mounting
GB2363371B (en) Liquid measure
CA90858S (en) Teapot
CA95829S (en) Teapot
AU4032601A (en) Liquid metering
GB0023069D0 (en) Formulation
GB0001144D0 (en) Glysophosate formulation
GB0004124D0 (en) Formulation
GB0010846D0 (en) Formulation
GB0015078D0 (en) Pharmaceutical solution
TW429946U (en) Improved container structure
TW424756U (en) Improved container structure
GB0100735D0 (en) Combustion solution
HU0001554D0 (en) Small percolator

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130423